Randomized Controlled Trial to Study Interventions to Increase Participation in Cervical Cancer Screening Program
1 other identifier
interventional
8,800
0 countries
N/A
Brief Summary
Women who don't participate in Swedish cytology screening program are a minority of about 10%, but constitute the majority of those who acquire cervical cancer. Over 50 000 women in the Västra Götalandregion have abstained from participation in the program for at least 2 screening rounds (6 - 10 years, depending om age). We plan to test two promising strategies to increase participation. In a study of two different health policies women who have defaulted are randomised to receiving a telephone call from a midwife, receive an offer of a self-test for HPV or being included in a control group. This is an effectiveness study that should give an answer how participation could be increased and give the basis for a calculation of the costs involved, before decisions can be made about implementing either intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for early_phase_1
Started Sep 2009
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2009
CompletedFirst Submitted
Initial submission to the registry
December 9, 2009
CompletedFirst Posted
Study publicly available on registry
December 10, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2011
CompletedAugust 30, 2012
August 1, 2012
5 months
December 9, 2009
August 29, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Frequency of testing (cytology in arm A and C and HPV-test in arm B). F
7 months after invitation
Frequency of further assessment of abnormal tests
7 months
Secondary Outcomes (5)
Frequency of abnormal smears. (Arm A vs arm C)
7 months
Frequency of treated CIN (Arm A vs. arm C)
7 months
Number of invasive cancers detected classified by FIGO stadium.
7 months
Cost of interventions
7 months
Cost per CIN2+ found and treated
7 months
Study Arms (3)
Telephone arm
EXPERIMENTALA midwife tries to contact the woman by telephone and offer her an appointment for a PAP-smear
Self-test arm
EXPERIMENTALControl arm
NO INTERVENTIONNo intervention other than what is routine in the screening program
Interventions
Midwifes at 72 antenatal care units in West region of Sweden receive lists with names and telephone numbers on women who have no record of screening during two screening rounds (6 - 10 years depending on age). The midwife will make up to ten attempts to reach each woman and is instructed to use no more than 30 minutes on this. If the midwife get in touch with the woman she will encourage participation in regular screening (run by midwives in Sweden) and help the woman to get an appointment.
Women receive an offer to order a vaginal self test for HPV. The woman can return a coupon in a postage free envelope and she will receive a self testing kit (dry method) within a couple of days. She will return the test in another postage free envelope. A reminder will be sent to women who order a test but do not return it.
Eligibility Criteria
You may qualify if:
- No record of PAP smear in the regional screening register for more than two screening rounds (6 - 10 years depending on age).
- Evidence in the regional population register that women have been living in the west region of Sweden during this time.
You may not qualify if:
- Total hysterectomy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Göteborg Universitylead
- Vastra Gotaland Regioncollaborator
- Assar Gabrielsson Cancer Foundation, Swedencollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Björn Strander, MD, PhD
Göteborg University
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 9, 2009
First Posted
December 10, 2009
Study Start
September 1, 2009
Primary Completion
February 1, 2010
Study Completion
January 1, 2011
Last Updated
August 30, 2012
Record last verified: 2012-08